HLA-DRB1 and classic Hodgkin lymphoma: EBV− cHL patients carrying the HLA-DRB1*15/16 risk allele more frequently retained HLA class II expression (69% vs. 52%, p = 0.007), consistent with our hypothesis (Figure 2A,B).